Short Bowel Syndrome Market 2017 Trend, Analysis and Forecast to 2021
ReportsWeb.com published “Short Bowel Syndrome Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, August 16, 2017 ) Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition. Based on drug class, the market is segmented into GLP-2, growth hormone, glutamine, and others.
Publisher’s analysts forecast the global short bowel syndrome (SBS) market to grow at a CAGR of 25.53% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-short-bowel-syndrome-sbs-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global short bowel syndrome (SBS) market for 2017-2021. To calculate the market size, the report considers the sales of the drugs and related nutraceutical products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Publisher's report, Global Short Bowel Syndrome (SBS) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Emmaus Medical
• Merck
• Shire
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001819100/sample .
Other prominent vendors
• Ardelyx
• Naia Pharmaceuticals
• Nutrinia
• OxThera
• Sancilio Pharmaceuticals
• Zealand Pharma
Market driver
• Special drug designations
• For a full, detailed list, view our report
Market challenge
• Severe side effects of the drugs
• For a full, detailed list, view our report
Market trend
• Increased awareness of GI disorders
• For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001819100/buying .
Publisher’s analysts forecast the global short bowel syndrome (SBS) market to grow at a CAGR of 25.53% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-short-bowel-syndrome-sbs-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global short bowel syndrome (SBS) market for 2017-2021. To calculate the market size, the report considers the sales of the drugs and related nutraceutical products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Publisher's report, Global Short Bowel Syndrome (SBS) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Emmaus Medical
• Merck
• Shire
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001819100/sample .
Other prominent vendors
• Ardelyx
• Naia Pharmaceuticals
• Nutrinia
• OxThera
• Sancilio Pharmaceuticals
• Zealand Pharma
Market driver
• Special drug designations
• For a full, detailed list, view our report
Market challenge
• Severe side effects of the drugs
• For a full, detailed list, view our report
Market trend
• Increased awareness of GI disorders
• For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001819100/buying .
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results